Advertisement

Topics

0.25% Acetic Acid Irrigation USP | Acetic Acid

05:23 EDT 27th August 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Package Insert

PIC™ (Plastic Irrigation Containers)

Urologic Irrigating Fluid for Patients Requiring ProlongedIndwelling Urethral Catheterization.Not for Transurethral Surgical Procedures.Not for Injection.

Each 100 mL contains:Glacial Acetic Acid USP 0.25 gWater for Injection USP qs

pH: 3.1 (2.8–3.4)Calculated Osmolarity: 42 mOsmol/liter

The formula of the active ingredient is:

0.25% Acetic Acid Irrigation USP is a prediluted, sterile, nonpyrogenic aqueous solution suitable for urologic irrigation. It contains no preservatives or added buffers. The solution is hypotonic.

The plastic container is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. The copolymer contains no plasticizers and exhibits virtually no leachability. The plastic container is also virtually impermeable to vapor transmission and therefore, requires no overwrap to maintain the proper drug concentration. The safety of the plastic container has been confirmed by biological evaluation procedures. The material passes Class Vl testing as specified in the U.S. Pharmacopeia for Biological Tests — Plastic Containers. These tests have shown that the container is nontoxic and biologically inert.

The PIC Container is PVC-free and DEHP-free.

Ingredient Molecular Formula Molecular Weight
Glacial Acetic Acid USP CH3COOH 60.05

Irrigation of the urinary bladder with acetic acid solution in a concentration of 0.25% has been shown to exert an antimicrobial action against a variety of microorganisms (especially ammonia-forming bacteria) that frequently gain access to the urinary bladder in patients who require prolonged indwelling urethral catheterization. Its antimicrobial action is dependent on administration via the indwelling catheter at a sufficient rate (continuous or intermittent) to maintain an effluent pH of 5.0 or lower. Maintenance of low pH of bladder urine also helps reduce formation of calcium encrustations in the indwelling catheter.

0.25% Acetic Acid Irrigation USP is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia-forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. It also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations.

0.25% Acetic Acid Irrigation USP is not for injection.

This solution is contraindicated for irrigation during transurethral surgical procedures.

FOR UROLOGIC IRRIGATION ONLY. NOT FOR INJECTION.

Use of this solution in patients with mucosal lesions of the urinary bladder may be harmful due to irritation of the lesion. Absorption via open lesions of the bladder mucosa may result in systemic acidosis.

Do not warm above 150°F (66°C).

After opening container, the contents should be used promptly in order to minimize the possibility of bacterial growth or pyrogen formation.

Discard unused portion of irrigating solution since it contains no preservative.

Use aseptic technique when preparing and administering sterile irrigation solutions.

Use only if solution is clear and container and seal are intact.

If pain or hematuria should occur during irrigation, it should be discontinued and the patient reevaluated.

When used for irrigation via appropriate irrigation equipment, the administration set should be attached promptly. Unused portions should be discarded and a fresh container of appropriate size used for the start up of each cycle or repeat procedure. For repeated irrigations of urethral catheters, a separate container should be used for each patient.

Studies with 0.25% Acetic Acid Irrigation USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

Animal reproduction studies have not been conducted with 0.25% Acetic Acid Irrigation USP. It is also not known whether 0.25% Acetic Acid Irrigation USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 0.25% Acetic Acid Irrigation USP should be given to a pregnant woman only if clearly needed.

Caution should be exercised when 0.25% Acetic Acid Irrigation USP is administered to a nursing woman.

Safety and effectiveness in pediatric patients have not been established.

Clinical studies of 0.25% Acetic Acid Irrigation USP have not been performed to determine whether patients over 65 years of age respond differently from younger subjects. Although systemic absorption of the product is unlikely, greater sensitivity of some older individuals cannot be ruled out.

Systemic acidosis, pain, and hematuria have been reported in patients receiving urinary bladder irrigation with 0.25% acetic acid solution.

If an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination, if deemed necessary.

Systemic absorption is unlikely unless there are open lesions of the bladder mucosa that have gone undetected. In such event, discontinue the irrigation, evaluate the patient for possible systemic acidosis, intravascular hemolysis, and circulatory overload and institute appropriate countermeasures as indicated. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS .

As required for urologic irrigation.

0.25% Acetic Acid Irrigation USP may be administered by gravity drip via an administration set connected to an indwelling urethral catheter designed for continuous or intermittent two-way flow.

For continuous or intermittent irrigation, the rate of administration will correspond roughly to the rate of urine flow and should be adjusted to maintain a urinary effluent pH of 4.5 to 5.0.

Nitrazine or other pH paper may be used to monitor pH, preferably at least four times daily. Drip rate should be adjusted as necessary to maintain desired pH; increasing flow rate reduces pH value and vice versa. With continuous or intermittent irrigation, each patient will require a volume of approximately 500 to 1500 mL per 24 hours.

Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.

This drug product should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

0.25% Acetic Acid Irrigation USP is supplied sterile and nonpyrogenic in 1000 mL and 500 mL PIC™ (Plastic Irrigation Containers) packaged 16 per case.

NDC Cat. No. Size
0.25% Acetic Acid Irrigation USP
0264-2304-00 R6600-01 1000 mL
0264-2304-10 R6601-01 500 mL

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.

Do not warm above 150°F (66°C).

Rx only

Revised: March 2009

PIC is a trademark of B. Braun Medical Inc.

Not for injection.

Aseptic technique is required.

Use only if solution is clear and container and seal are intact.

Single dose container. Discard unused portion.

IMAGE acetic-acid-01.jpgIMAGE acetic-acid-02.jpg

B. Braun Medical Inc. Irvine, CA 92614-5895 USAMade in USA

Y36-002-694

0.25% Acetic AcidIrrigation USP

REF R6600-01NDC 0264-2304-00 1000 mL

Each 100 mL contains:Glacial Acetic Acid USP 0.25 gWater for Injection USP qs

pH: 3.1 (2.8–3.4)Calc. Osmolarity: 42 mOsmol/liter,hypotonic

Not for Injection or TransurethralSurgery: Use only if solution is clear andcontainer and seal are intact.

Sterile, nonpyrogenic.Single dose container.

Warning: Do not warm above 150°F (66°C).

Recommended Storage:Room temperature (25°C).Avoid excessive heat.Protect from freezing.See Package Insert.

Rx only

PVC-free and DEHP-free

B. Braun Medical Inc. Irvine, CA 92614-5895 USAMade in USA

Lot.Exp.

Y37-002-327

IMAGE acetic-acid-03.jpg

0.25% Acetic AcidIrrigation USP

REF R6601-01NDC 0264-2304-10 500 mL

Each 100 mL contains:Glacial Acetic Acid USP 0.25 gWater for Injection USP qs

pH: 3.1 (2.8–3.4)Calc. Osmolarity: 42 mOsmol/liter,hypotonic

Not for Injection or TransurethralSurgery: Use only if solution is clear andcontainer and seal are intact.

Sterile, nonpyrogenic.Single dose container.

Warning: Do not warm above 150°F (66°C).

Recommended Storage:Room temperature (25°C).Avoid excessive heat.Protect from freezing.See Package Insert.

Rx only

PVC-free and DEHP-free

B. Braun Medical Inc. Irvine, CA 92614-5895 USAMade in USA

Lot.Exp.

Y37-002-328

IMAGE acetic-acid-04.jpg

Manufacturer

B. Braun Medical Inc.

Active Ingredients

Source

Drugs and Medications [82 Associated Drugs and Medications listed on BioPortfolio]

Acetic acid [Hi-Tech Pharmacal Co., Inc.]

Acetic Acid Otic Solution, USP

Acetic acid [Qualitest Pharmaceuticals]

ACETIC ACID OTIC SOLUTION, USP

Borofair [Major Pharmaceuticals]

Acetic Acid in AqueousAluminum Acetate

Acetic acid [Bausch & Lomb Incorporated]

Acetic Acid 2% in AqueousAluminum Acetate Otic Solution

Hydrocortisone and acetic acid [Hi-Tech Pharmacal Co., Inc.]

Hydrocortisone and Acetic Acid Otic Solution, USP

Clinical Trials [1747 Associated Clinical Trials listed on BioPortfolio]

Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery

RATIONALE: Drugs used in chemotherapy such as gossypol acetic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing....

Impact of Intraduodenal Acetic Acid Infusion on Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Double-blind, Randomized Controlled Trial

Intraduodenal acetic acid can stimulate secretion of water and bicarbonate from pancreatic ductal cells. In this study, acetic acid spraying to duodenal bulb was compared with saline solut...

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

Neoplasia in Barrett's esophagus could be missed during routine random biopsies. We propose a study using chromoendoscopy with Acetic Acid to increase the yield of biopsies in detecting ne...

Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from di...

Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

This phase I/II trial studies the side effects and best dose of lenalidomide when given together with R-(-)-gossypol acetic acid and to see how well they work in treating patients with rel...

PubMed Articles [7460 Associated PubMed Articles listed on BioPortfolio]

Heterogeneous Reactions of Acetic Acid with Oxide Surfaces: Effects of Mineralogy and Relative Humidity.

We have investigated the heterogeneous uptake of gaseous acetic acid on different oxides including γ-Al2O3, SiO2, and CaO under a range of relative humidity conditions. Under dry conditions, the upta...

Polygenic analysis and targeted improvement of the complex trait of high acetic acid tolerance in the yeast Saccharomyces cerevisiae.

Acetic acid is one of the major inhibitors in lignocellulose hydrolysates used for the production of second-generation bioethanol. Although several genes have been identified in laboratory yeast strai...

Effects of oxygen availability on acetic acid tolerance and intracellular pH in Dekkera bruxellensis.

The yeast Dekkera bruxellensis, associated with wine and beer production, has recently received attention because its high ethanol and acid tolerance enables it to compete with Saccharomyces cerevisia...

Improved acetic acid resistance in Saccharomyces cerevisiae by overexpression of the WHI2 gene identified through inverse metabolic engineering.

Developing acetic acid resistant Saccharomyces cerevisiae is important for economically viable production of biofuels from lignocellulosic biomass, but the goal remains a critical challenge due to lim...

Culture strategies for lipid production using acetic acid as sole carbon source by Rhodosporidium toruloides.

Rhodosporidium toruloides AS 2.1389 was tested using different concentrations of acetic acid as a low-cost carbon source for the production of microbial lipids, which are good raw materials for biodie...

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record